An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical practice, according to a study published in the journal Oncology Reports.
Molecular oncologist Fumihiro Higashino and colleagues deleted a gene involved in viral replication, called E4orf6, from a type of adenovirus. The team previously discovered that E4orf6 stabilizes a type of mRNA called ARE-mRNAs in the infected cells enabling viral replication. ARE-mRNAs are known to be stable in stressed cells and cancer cells, but rapidly degrade in normal cells.
In laboratory tests, they found that their modified adenovirus, called dl355, replicated and increased its number significantly more in cancer cells than it did in normal cells. Higashino explains “The E4orf6-lacking virus relies on the stable ARE-mRNAs in cancer cells for its replication.”
Some viruses can be used to treat cancers, as they replicate within the cells until they burst and die. The researchers infected several types of cultured cancer cells with 100 dl355 virus particles per cell and found that nearly all the cancer cells died within seven days. In contrast, most normal cells infected with the virus did not die, even after seven days. Several cancer cell lines managed to survive low doses of dl355, but all cancer cells were killed by the virus as the dose was increased. Tumour growth was also significantly suppressed when dl355 was administered to human tumour cells grown in mice.
Finally, the team compared the anticancer effects of dl355 with another anticancer adenovirus currently used in clinical practice, called dl1520. dl355 replication was higher in all cancer cell lines tested, including cervical and lung cancer cells, and was better at killing all but one type of cancer cell, compared to dl1520. Both viruses only killed very few normal cells.
The findings suggest that dl355 has potential to be an effective anticancer treatment, the team concludes. They suggest enhancing the stabilization of ARE-mRNAs in cancer cells could even further strengthen its effect, but Professor Higashino notes that further research is required. “While we think dl355 has the potential to be an effective treatment method in dealing with many types of cancers, much more research needs to be done. When we think of a timeline, at least five more years of further research may be required, possible more, on top of clinical trials,” Professor Higashino noted.
Learn more: Engineering a cancer-fighting virus
The Latest on: Engineered virus
[google_news title=”” keyword=”engineered virus” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Engineered virus
- Can CRISPR help stop African Swine Fever?on April 26, 2024 at 5:00 pm
By working together, the research teams built multiple modified viruses. “In combination, we generated over 30 different recombinant viruses that can be tested for attenuation and protection as ...
- Common antibiotic Neosporin may shield against viral respiratory infectionson April 26, 2024 at 9:00 am
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- Genetically modified mice reveal key players in immune defense against viruseson April 25, 2024 at 11:00 pm
Chemokines are signaling proteins that orchestrate the interaction of immune cells against pathogens and tumors.
- MIT study reveals circadian impact on drug metabolism in engineered liverson April 25, 2024 at 10:51 pm
Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.
- Vaccine breakthrough means no more chasing strainson April 25, 2024 at 11:10 am
Scientists at UC Riverside have devised a vaccine that targets a part of the viral genome that is common to all strains of a given virus.
- A woman with failing kidneys receives genetically modified pig organson April 24, 2024 at 10:00 am
Surgeons transplanted a kidney and thymus gland from a gene-edited pig into a 54-year-old woman in an attempt to extend her life. It's the latest experimental use of animal organs in humans.
- Zoetis gets grant for vaccine for protecting porcine animals from prrs viruson April 24, 2024 at 6:08 am
Protect your porcine animals from PRRS virus with Zoetis Inc's patented vaccine method. Administer before weaning for safe, effective protection.
- A one-shot vaccine for COVID, flu and future viruses? Researchers say it's comingon April 18, 2024 at 3:43 pm
But what if it were possible to protect against COVID and the flu, and other unknown viruses that haven't yet emerged, with just one shot? If that became reality, seasonal or annual boosters would be ...
- Aaron Rodgers thinks the government engineered HIV, and 9 other unhinged things he's saidon April 18, 2024 at 9:25 am
Aaron Rodgers is at it again. The perpetually controversial quarterback is making headlines, after a clip of him suggesting the HIV/AIDS crisis was purposely created by the United States government ...
- New Vaccine Could Protect Against Any Strain of a Virus With One Shoton April 18, 2024 at 6:43 am
Scientists seem to be close to creating a "one-and-done" vaccine that can protect against any strain of a virus with just one shot.
via Bing News